These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 12691208)

  • 21. MDMA to Treat PTSD in Adults.
    Latimer D; Stocker MD; Sayers K; Green J; Kaye AM; Abd-Elsayed A; Cornett EM; Kaye AD; Varrassi G; Viswanath O; Urits I
    Psychopharmacol Bull; 2021 Jun; 51(3):125-149. PubMed ID: 34421149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Psychedelic Therapy Scrutinized by FDA Advisory Committee?
    Marks M
    JAMA; 2024 Sep; 332(12):963-964. PubMed ID: 39078646
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Why MDMA therapy for alcohol use disorder? And why now?
    Sessa B
    Neuropharmacology; 2018 Nov; 142():83-88. PubMed ID: 29126911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Front Psychiatry; 2019; 10():650. PubMed ID: 31572236
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin.
    Varker T; Watson L; Gibson K; Forbes D; O'Donnell ML
    J Psychoactive Drugs; 2021; 53(1):85-95. PubMed ID: 32931403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential use of N-methyl-3,4-methylenedioxyamphetamine (MDMA) assisted psychotherapy in the treatment of eating disorders comorbid with PTSD.
    Brewerton TD; Lafrance A; Mithoefer MC
    Med Hypotheses; 2021 Jan; 146():110367. PubMed ID: 33203569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sleep Quality Improvements After MDMA-Assisted Psychotherapy for the Treatment of Posttraumatic Stress Disorder.
    Ponte L; Jerome L; Hamilton S; Mithoefer MC; Yazar-Klosinski BB; Vermetten E; Feduccia AA
    J Trauma Stress; 2021 Aug; 34(4):851-863. PubMed ID: 34114250
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How could MDMA (ecstasy) help anxiety disorders? A neurobiological rationale.
    Johansen PØ; Krebs TS
    J Psychopharmacol; 2009 Jun; 23(4):389-91. PubMed ID: 19273493
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Breakthrough for Trauma Treatment: Safety and Efficacy of MDMA-Assisted Psychotherapy Compared to Paroxetine and Sertraline.
    Feduccia AA; Jerome L; Yazar-Klosinski B; Emerson A; Mithoefer MC; Doblin R
    Focus (Am Psychiatr Publ); 2023 Jul; 21(3):306-314. PubMed ID: 37404974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation.
    Raut SB; Marathe PA; van Eijk L; Eri R; Ravindran M; Benedek DM; Ursano RJ; Canales JJ; Johnson LR
    Pharmacol Ther; 2022 Nov; 239():108195. PubMed ID: 35489438
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant drugs associated with increased mortality for MDMA users reported in a drug safety surveillance database.
    Cohen IV; Makunts T; Abagyan R; Thomas K
    Sci Rep; 2021 Mar; 11(1):5997. PubMed ID: 33727616
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3,4-Methylenedioxymethamphetamine's (MDMA's) Impact on Posttraumatic Stress Disorder.
    White CM
    Ann Pharmacother; 2014 Jul; 48(7):908-915. PubMed ID: 24740469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Costs and Health Benefits of Expanded Access to MDMA-assisted Therapy for Chronic and Severe PTSD in the USA: A Modeling Study.
    Avanceña ALV; Kahn JG; Marseille E
    Clin Drug Investig; 2022 Mar; 42(3):243-252. PubMed ID: 35230652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psilocybin and MDMA for the treatment of trauma-related psychopathology.
    Bird CIV; Modlin NL; Rucker JJH
    Int Rev Psychiatry; 2021 May; 33(3):229-249. PubMed ID: 34121583
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Why Psychiatry Needs 3,4-Methylenedioxymethamphetamine: A Child Psychiatrist's Perspective.
    Sessa B
    Neurotherapeutics; 2017 Jul; 14(3):741-749. PubMed ID: 28477247
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expert opinions on implementation of MDMA-assisted therapy in Europe: critical appraisal towards training, clinical practice, and regulation.
    Herpers J; Maximets N; van Dongen NNN; Zijlmans J; Vermetten E
    Eur J Psychotraumatol; 2024; 15(1):2378651. PubMed ID: 39113624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulatory and scientific issues regarding use of foreign data in support of new drug applications in the United States: an FDA perspective.
    Khin NA; Yang P; Hung HM; Maung-U K; Chen YF; Meeker-O'Connell A; Okwesili P; Yasuda SU; Ball LK; Huang SM; O'Neill RT; Temple R
    Clin Pharmacol Ther; 2013 Aug; 94(2):230-42. PubMed ID: 23588316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA-assisted therapy: A new treatment model for social anxiety in autistic adults.
    Danforth AL; Struble CM; Yazar-Klosinski B; Grob CS
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Jan; 64():237-49. PubMed ID: 25818246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lessons learned from independent central review.
    Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
    Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDMA assisted therapy: Three papers are retracted as FDA rejects PTSD application.
    Mahase E
    BMJ; 2024 Aug; 386():q1798. PubMed ID: 39137950
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.